Abstract:The periostin protein, encoded by the POSTN gene, is a component of the extracellular matrix, which is expressed by fibroblasts and has been observed in a variety of human malignancies. The present study aimed to detect the expression of periostin in the tissues of non-small cell lung cancer (NSCLC) patients and benign lung tumors, and to correlate the results with the clinicopathological data of the subjects, in order to evaluate periostin as a potential prognostic marker. In total, 49 NSCLC patients and 6 benign lung tumors were included in this study. The protein level of periostin was detected in paired normal/paratumor/cancer tissues by a western blot analysis and the mRNA level in paired normal/cancer tissues was detected by quantitative polymerase chain reaction (qPCR). The results were then correlated with established biological and prognostic factors. Immunohistochemistry was used to confirm the location of periostin in the NSCLC tissues. Uni- and multivariate analyses were performed using Cox's proportional hazards regression model. The protein level of periostin was elevated in the cancer tissue of the NSCLC patients compared with the normal (P=0.017) and paratumor (P=0.000) tissues. The expression level in the male patients was much higher than in the female patients at the protein (P=0.001) and mRNA (P=0.010) levels. The mRNA level in the non-adenocarcinoma (non-ADC) patients was much higher than in the adenocarcinoma (ADC) patients (P=0.029). Periostin was demonstrated higher expression at the protein level in the pseudotumors and tuberculosis patients than in the adjacent (P=0.016) and surrounding tissues (P=0.001). Immunostaining indicated that high levels of periostin were present in the mesenchymal areas, but not in the cancer cells themselves. The patients with tumors exhibiting high-level periostin expression showed a significantly shorter survival time (P=0.036, log-rank test). The 3-year survival rate was 81.5% for patients with low-level periostin expression (periostin-L; n=27) and 45.4% for patients with high-level periostin expression (periostin-H; n=22). Similarly, pathological node (pN) status was a significant prognostic marker in the univariate Cox survival analysis. Notably, periostin-H expression was also identified as an independent prognostic factor by the multivariate analysis (P=0.011). These results showed that the overexpression of periostin predicts a poor prognosis, therefore it may be regarded as a novel molecule in the progression and development of NSCLC. The results provide an additional target for the adjuvant treatment of NSCLC.

Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma

Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.

Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma.

Overexpression of Periostin Predicts Poor Prognosis in Non-Small Cell Lung Cancer.

Overexpression Of Periostin Is Significantly Correlated To The Tumor Angiogenesis And Poor Prognosis In Patients With Esophageal Squamous Cell Carcinoma

TGFβ3-mediated Induction of Periostin Facilitates Head and Neck Cancer Growth and is Associated with Metastasis

Activation of Akt/mTOR Pathway Is Associated with Poor Prognosis of Nasopharyngeal Carcinoma

A novel proteomic prognostic signature characterizes the immune landscape and predicts nasopharyngeal carcinoma prognosis

Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma

Survival Analyses Correlate Stanniocalcin 2 Overexpression to Poor Prognosis of Nasopharyngeal Carcinomas

Periostin acts as an oncogene to promote laryngeal cancer progression by activating decorin

The miRNA-185-5p/STIM1 Axis Regulates the Invasiveness of Nasopharyngeal Carcinoma Cell Lines by Modulating EGFR Activation-Stimulated Switch from E- to N-Cadherin

Osteopontin Is A Useful Predictor Of Bone Metastasis And Survival In Patients With Locally Advanced Nasopharyngeal Carcinoma

Association Between Periostin and Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma and Its Clinical Significance.

Novel prognostic biomarkers in nasopharyngeal carcinoma unveiled by mega-data bioinformatics analysis

Correlation between Periostin Expression and Pro-Angiogenic Factors in Non-Small-Cell Lung Carcinoma

High expression of Zinc-finger protein X-linked is associated with reduced E-cadherin expression and unfavorable prognosis in nasopharyngeal carcinoma.

Nasopharyngeal Carcinoma:Correlation Between Peripheral Deeper Infiltration and Prognosis and Expression of P53 Protein

Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma

Combined Upregulation of Matrix Metalloproteinase-1 and Proteinase-Activated Receptor-1 Predicts Unfavorable Prognosis in Human Nasopharyngeal Carcinoma

Periostin, a Matrix Specific Protein, is Associated with Proliferation and Invasion of Pancreatic Cancer